Ling Bi

4PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersMolecular targetsTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 20, 2025
Inhibition of Dormant Lung Cancer Cell Reactivation by Punica Granatum Peel and Dioscorea Nipponica: Involving MYC, SKP2 and p27.

Su Su Thae Hnit, Ling Bi, Chanlu Xie

|Oct 04, 2022
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma.

Ming-Yu Luo, Ye Zhou, Wei-Ming Gu

|Dec 23, 2021
Anticancer Action of Xiaoxianxiong Tang in Non-Small Cell Lung Cancer by Pharmacological Analysis and Experimental Validation.

Rongzhen Ding, Lijing Jiao, Shuliu Sang

|Jan 22, 2020
CPF impedes cell cycle re-entry of quiescent lung cancer cells through transcriptional suppression of FACT and c-MYC.

Ling Bi, Chanlu Xie, Lijing Jiao

Pageof 1

Frequent Collaborators

1 joint publications

Xiaodong Zhao

1 joint publications

Ling Xu

1 joint publications

Ming-Yu Luo

1 joint publications

Liang Zhu